Cargando…

Cephalosporin's induced hepatic enzyme derangement - An educational report

Detalles Bibliográficos
Autores principales:	Thangaraju, Pugazhenthan, Varthya, Shoban Babu, Guruthalingam, Meenalotchini Prakash, Venkatesan, Sajitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346957/ https://www.ncbi.nlm.nih.gov/pubmed/32670987 http://dx.doi.org/10.4103/jfmpc.jfmpc_1133_19

Ejemplares similares

Named terminologies of patient-centered – A focus respective to stigmatized disease
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Low-dose oxytocin - a safe strategy in postpartum hemorrhage
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Curcumin and fungal infection – commonly available herbs for common female infection
por: Varthya, Shoban Babu, et al.
Publicado: (2020)

Fixed-dose combinations: An essential for rational preparation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Chloroquine induced utricaria—A detailed history helps
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Target/therapies for chronic recurrent erythema nodosum leprosum
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Clofazimine induced methemoglobinemia – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Leprosy cases with respiratory infection – Rule out tuberculosis simultaneously with dapsone syndrome
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2018)

Monotherapy with liraglutide – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Medical residents: Research and publication priorities/confusions
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Responding to the Global Guidelines for the Prevention of Surgical Site Infection, 2018: A focus on surgical antibiotic prophylaxis prolongation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Current treatment guideline by the World Health Organization against leprosy: A positive focus
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Government of India initiative against leprosy—We should be aware
por: Venkatesan, Sajitha, et al.
Publicado: (2019)

Health strategy in South State of India – Towards older people
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Leprosy - the current target in national programmes
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Final Leprosy Push: Out of Society
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2018)

Paediatric dosage ‘need of hours among family physicians/other speciality physicians’
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Leprosy in Children: Needs for Active Intervention
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2018)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2017)

Leprosy reactions: Earlier diagnosis leads to more effective treatment
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Are We Jumping the Gun with Itolizumab in India? A Situational Analysis from the Pre-COVID Era
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Regulatory approval for COVID-19 across the globe
por: Mahalmani, Vidya, et al.
Publicado: (2020)

Decentralisation of healthcare system due to COVID-19 and its impact on hospital based laboratories - Pandemic panic patients’ reflection?
por: Jayamani, Jayagandan, et al.
Publicado: (2020)

Information on migraine drugs in commonly available Indian drug information sources – Whether we satisfied the community needs?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Role of Dupilumab in Approved Indications of COVID-19 Patient: an Efficacy-Based Nonsystematic Critical Analysis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Needs monitoring with quetiapine
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Violence against doctor – few points to be focussed
por: Thangaraju, Pugazhenthan
Publicado: (2020)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Does Remdesivir maintain the race in the general treatment protocol of COVID-19?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Diligence needed on treatment of primary multidrug-resistant pulmonary tuberculosis with concomitant COVID-19 infection
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Mycobacterium leprae or tuberculosis: A Diagnostic Dilemma
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2017)

Gestational diabetes: Unfolded area still a concern
por: Velmurugan, Hemasri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_frborrv3cffcr9fjpkgoucsd14